Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 15Ovarian Neoplasms 3Colorectal Neoplasms 3Neoplasms, Unknown Primary 2Hereditary Breast and Ovarian Cancer Syndrome 2Carcinoma, Intraductal, Noninfiltrating 2Brain Neoplasms 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Urogenital Neoplasms 1Primary Ovarian Insufficiency 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Hot Flashes 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Digestive System Neoplasms 1Depression 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Breast Screening 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Anatomic Stage II Breast Cancer AJCC v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

entinostat 2ribociclib 1pembrolizumab 1palbociclib 1olaparib 1alectinib 1Tinzaparin 1Sorafenib 1Paclitaxel 1Genetic Testing 1Genetic Counseling 1Fulvestrant 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × Genetic Testing × Breast × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡